256 related articles for article (PubMed ID: 15778293)
1. Ku70 acetylation mediates neuroblastoma cell death induced by histone deacetylase inhibitors.
Subramanian C; Opipari AW; Bian X; Castle VP; Kwok RP
Proc Natl Acad Sci U S A; 2005 Mar; 102(13):4842-7. PubMed ID: 15778293
[TBL] [Abstract][Full Text] [Related]
2. CREB-binding protein is a mediator of neuroblastoma cell death induced by the histone deacetylase inhibitor trichostatin A.
Subramanian C; Jarzembowski JA; Opipari AW; Castle VP; Kwok RP
Neoplasia; 2007 Jun; 9(6):495-503. PubMed ID: 17603632
[TBL] [Abstract][Full Text] [Related]
3. CLU blocks HDACI-mediated killing of neuroblastoma.
Subramanian C; Jarzembowski JA; Halsey SM; Kuick R; Opipari AW; Castle VP; Kwok RP
Tumour Biol; 2011 Apr; 32(2):285-94. PubMed ID: 21042904
[TBL] [Abstract][Full Text] [Related]
4. Ectopic expression of Bcl-XL or Ku70 protects human colon cancer cells (SW480) against curcumin-induced apoptosis while their down-regulation potentiates it.
Rashmi R; Kumar S; Karunagaran D
Carcinogenesis; 2004 Oct; 25(10):1867-77. PubMed ID: 15205359
[TBL] [Abstract][Full Text] [Related]
5. HDAC6 deacetylates Ku70 and regulates Ku70-Bax binding in neuroblastoma.
Subramanian C; Jarzembowski JA; Opipari AW; Castle VP; Kwok RP
Neoplasia; 2011 Aug; 13(8):726-34. PubMed ID: 21847364
[TBL] [Abstract][Full Text] [Related]
6. Ku70 is essential for histone deacetylase inhibitor trichostatin A-induced apoptosis.
Meng J; Zhang F; Zhang XT; Zhang T; Li YH; Fan L; Sun Y; Zhang HL; Mei QB
Mol Med Rep; 2015 Jul; 12(1):581-6. PubMed ID: 25695595
[TBL] [Abstract][Full Text] [Related]
7. Histone deacetylase inhibitors strongly sensitise neuroblastoma cells to TRAIL-induced apoptosis by a caspases-dependent increase of the pro- to anti-apoptotic proteins ratio.
Mühlethaler-Mottet A; Flahaut M; Bourloud KB; Auderset K; Meier R; Joseph JM; Gross N
BMC Cancer; 2006 Aug; 6():214. PubMed ID: 16930472
[TBL] [Abstract][Full Text] [Related]
8. Histone deacetylase inhibitors sensitize lung cancer cells to hyperthermia: involvement of Ku70/SirT-1 in thermo-protection.
Hassan MK; Watari H; Salah-Eldin AE; Sultan AS; Mohamed Z; Fujioka Y; Ohba Y; Sakuragi N
PLoS One; 2014; 9(4):e94213. PubMed ID: 24728004
[TBL] [Abstract][Full Text] [Related]
9. The novel histone deacetylase inhibitor, N-hydroxy-7-(2-naphthylthio) hepatonomide, exhibits potent antitumor activity due to cytochrome-c-release-mediated apoptosis in renal cell carcinoma cells.
Park KC; Heo JH; Jeon JY; Choi HJ; Jo AR; Kim SW; Kwon HJ; Hong SJ; Han KS
BMC Cancer; 2015 Jan; 15():19. PubMed ID: 25613585
[TBL] [Abstract][Full Text] [Related]
10. CREB-binding protein regulates Ku70 acetylation in response to ionization radiation in neuroblastoma.
Subramanian C; Hada M; Opipari AW; Castle VP; Kwok RP
Mol Cancer Res; 2013 Feb; 11(2):173-81. PubMed ID: 23223795
[TBL] [Abstract][Full Text] [Related]
11. Acetylation of the C terminus of Ku70 by CBP and PCAF controls Bax-mediated apoptosis.
Cohen HY; Lavu S; Bitterman KJ; Hekking B; Imahiyerobo TA; Miller C; Frye R; Ploegh H; Kessler BM; Sinclair DA
Mol Cell; 2004 Mar; 13(5):627-38. PubMed ID: 15023334
[TBL] [Abstract][Full Text] [Related]
12. Maspin increases Ku70 acetylation and Bax-mediated cell death in cancer cells.
Lee SJ; Jang H; Park C
Int J Mol Med; 2012 Feb; 29(2):225-30. PubMed ID: 22076034
[TBL] [Abstract][Full Text] [Related]
13. Histone deacetylase inhibitor depsipeptide (FK228) induces apoptosis in leukemic cells by facilitating mitochondrial translocation of Bax, which is enhanced by the proteasome inhibitor bortezomib.
Sutheesophon K; Kobayashi Y; Takatoku MA; Ozawa K; Kano Y; Ishii H; Furukawa Y
Acta Haematol; 2006; 115(1-2):78-90. PubMed ID: 16424655
[TBL] [Abstract][Full Text] [Related]
14. Cytosolic Ku70 regulates Bax-mediated cell death.
Hada M; Subramanian C; Andrews PC; Kwok RP
Tumour Biol; 2016 Oct; 37(10):13903-13914. PubMed ID: 27488115
[TBL] [Abstract][Full Text] [Related]
15. Identification of an acetylation-dependant Ku70/FLIP complex that regulates FLIP expression and HDAC inhibitor-induced apoptosis.
Kerr E; Holohan C; McLaughlin KM; Majkut J; Dolan S; Redmond K; Riley J; McLaughlin K; Stasik I; Crudden M; Van Schaeybroeck S; Fenning C; O'Connor R; Kiely P; Sgobba M; Haigh D; Johnston PG; Longley DB
Cell Death Differ; 2012 Aug; 19(8):1317-27. PubMed ID: 22322857
[TBL] [Abstract][Full Text] [Related]
16. Coadministration of histone deacetylase inhibitors and perifosine synergistically induces apoptosis in human leukemia cells through Akt and ERK1/2 inactivation and the generation of ceramide and reactive oxygen species.
Rahmani M; Reese E; Dai Y; Bauer C; Payne SG; Dent P; Spiegel S; Grant S
Cancer Res; 2005 Mar; 65(6):2422-32. PubMed ID: 15781658
[TBL] [Abstract][Full Text] [Related]
17. Histone deacetylase inhibitors sensitize prostate cancer cells to agents that produce DNA double-strand breaks by targeting Ku70 acetylation.
Chen CS; Wang YC; Yang HC; Huang PH; Kulp SK; Yang CC; Lu YS; Matsuyama S; Chen CY; Chen CS
Cancer Res; 2007 Jun; 67(11):5318-27. PubMed ID: 17545612
[TBL] [Abstract][Full Text] [Related]
18. Bax-inhibiting peptide protects cells from polyglutamine toxicity caused by Ku70 acetylation.
Li Y; Yokota T; Gama V; Yoshida T; Gomez JA; Ishikawa K; Sasaguri H; Cohen HY; Sinclair DA; Mizusawa H; Matsuyama S
Cell Death Differ; 2007 Dec; 14(12):2058-67. PubMed ID: 17885668
[TBL] [Abstract][Full Text] [Related]
19. Vorinostat-induced apoptosis in mantle cell lymphoma is mediated by acetylation of proapoptotic BH3-only gene promoters.
Xargay-Torrent S; López-Guerra M; Saborit-Villarroya I; Rosich L; Campo E; Roué G; Colomer D
Clin Cancer Res; 2011 Jun; 17(12):3956-68. PubMed ID: 21652541
[TBL] [Abstract][Full Text] [Related]
20. Histone deacetylase inhibitors radiosensitize human melanoma cells by suppressing DNA repair activity.
Munshi A; Kurland JF; Nishikawa T; Tanaka T; Hobbs ML; Tucker SL; Ismail S; Stevens C; Meyn RE
Clin Cancer Res; 2005 Jul; 11(13):4912-22. PubMed ID: 16000590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
